-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App, Xianjian Technology (01302.HK) announced that on January 7, 2026, the G-iliaTM Pro iliac artery stent system (G-iliaTM Pro or this product) independently developed by the company was officially registered and approved by the China National Drug Administration (China Drug Administration). This product is suitable for intracavitary treatment of abdominal aortic aneurysms combined with iliac aneurysms or isolated common iliac aneurysms. It ensures pelvic blood supply by reconstructing the internal iliac artery, provides a more mature and complete clinical solution, and enables a systematic upgrade of existing treatment plans.

Zhitongcaijing·01/08/2026 11:25:07
Listen to the news
According to Zhitong Finance App, Xianjian Technology (01302.HK) announced that on January 7, 2026, the G-iliaTM Pro iliac artery stent system (G-iliaTM Pro or this product) independently developed by the company was officially registered and approved by the China National Drug Administration (China Drug Administration). This product is suitable for intracavitary treatment of abdominal aortic aneurysms combined with iliac aneurysms or isolated common iliac aneurysms. It ensures pelvic blood supply by reconstructing the internal iliac artery, provides a more mature and complete clinical solution, and enables a systematic upgrade of existing treatment plans.